Crossmark

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways

Crossref DOI link: https://doi.org/10.1016/j.jacbts.2018.09.004

Published Print: 2018-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rakipovski, Günaj

Rolin, Bidda

Nøhr, Jane

Klewe, Ib

Frederiksen, Klaus S.

Augustin, Robert

Hecksher-Sørensen, Jacob

Ingvorsen, Camilla

Polex-Wolf, Joseph

Knudsen, Lotte Bjerre
License Information

Text and Data Mining valid from 2018-12-01

Text and Data Mining valid from 2018-12-01

Version of Record valid from 2018-09-25
More Information

This article is maintained by: Elsevier

Article Title: The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways

Journal Title: JACC: Basic to Translational Science

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacbts.2018.09.004

Content Type: article

Copyright: © 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.